Convidado

FELIPE ADES

SAO PAULO / SP

Oncologista clinico do hospital alemao oswaldo cruz e centro paulista de oncologia/grupo oncoclinicas, PhD no institut jules bordet/université libre de bruxelles, bélgica, Mestre pelo institu gustave roussy/université paris XI, frança

Imprimir

Atividades

24/03/2018

Plenária

08:45 às 09:35 - Session 4 - Best of SABCS 2017 - Parte 3

09:15 às 09:25 - GS3-04. A randomized phase III study of adjuvant trastuzumab for a duration of 9 weeks versus 1 year, combined with adjuvant taxane-anthracycline chemotherapy, for early HER2-positive breast cancer (the SOLD study)

Palestrante

Voltar